• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与来自正常供体的间充质干细胞相比,多发性骨髓瘤患者的间充质干细胞表现出不同的基因组特征。

Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors.

作者信息

Garayoa M, Garcia J L, Santamaria C, Garcia-Gomez A, Blanco J F, Pandiella A, Hernández J M, Sanchez-Guijo F M, del Cañizo M-C, Gutiérrez N C, San Miguel J F

机构信息

Centro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer, Universidad de Salamanca-CSIC, Salamanca, Spain.

出版信息

Leukemia. 2009 Aug;23(8):1515-27. doi: 10.1038/leu.2009.65. Epub 2009 Apr 9.

DOI:10.1038/leu.2009.65
PMID:19357701
Abstract

It is an open question whether in multiple myeloma (MM) bone marrow stromal cells contain genomic alterations, which may contribute to the pathogenesis of the disease. We conducted an array-based comparative genomic hybridization (array-CGH) analysis to compare the extent of unbalanced genomic alterations in mesenchymal stem cells from 21 myeloma patients (MM-MSCs) and 12 normal donors (ND-MSCs) after in vitro culture expansion. Whereas ND-MSCs were devoid of genomic imbalances, several non-recurrent chromosomal gains and losses (>1 Mb size) were detected in MM-MSCs. Using real-time reverse transcription PCR, we found correlative deregulated expression for five genes encoded in regions for which genomic imbalances were detected using array-CGH. In addition, only MM-MSCs showed a specific pattern of 'hot-spot' regions with discrete (<1 Mb) genomic alterations, some of which were confirmed using fluorescence in situ hybridization (FISH). Within MM-MSC samples, unsupervised cluster analysis did not correlate with particular clinicobiological features of MM patients. We also explored whether cytogenetic abnormalities present in myelomatous plasma cells (PCs) were shared by matching MSCs from the same patients using FISH. All MM-MSCs were cytogenetically normal for the tested genomic alterations. Therefore we cannot support a common progenitor for myeloma PCs and MSCs.

摘要

多发性骨髓瘤(MM)的骨髓基质细胞是否存在可能导致该疾病发病机制的基因组改变仍是一个悬而未决的问题。我们进行了基于阵列的比较基因组杂交(array-CGH)分析,以比较21例骨髓瘤患者的间充质干细胞(MM-MSCs)和12例正常供体的间充质干细胞(ND-MSCs)在体外培养扩增后的基因组不平衡改变程度。ND-MSCs没有基因组失衡,而在MM-MSCs中检测到了几种非复发性染色体增减(>1 Mb大小)。使用实时逆转录PCR,我们发现对于在使用array-CGH检测到基因组失衡的区域中编码的五个基因,存在相关的表达失调。此外,只有MM-MSCs显示出具有离散(<1 Mb)基因组改变的“热点”区域的特定模式,其中一些使用荧光原位杂交(FISH)得到了证实。在MM-MSC样本中,无监督聚类分析与MM患者的特定临床生物学特征无关。我们还使用FISH探索了骨髓瘤浆细胞(PCs)中存在的细胞遗传学异常是否与来自同一患者的匹配MSCs共有。对于测试的基因组改变,所有MM-MSCs的细胞遗传学均正常。因此,我们不支持骨髓瘤PCs和MSCs有共同祖细胞的观点。

相似文献

1
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors.与来自正常供体的间充质干细胞相比,多发性骨髓瘤患者的间充质干细胞表现出不同的基因组特征。
Leukemia. 2009 Aug;23(8):1515-27. doi: 10.1038/leu.2009.65. Epub 2009 Apr 9.
2
Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.与多发性骨髓瘤细胞相互作用后骨髓间充质基质细胞中诱导的转录组谱:对骨髓瘤进展和骨髓瘤骨病的影响
Oncotarget. 2014 Sep 30;5(18):8284-305. doi: 10.18632/oncotarget.2058.
3
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.人骨髓间充质干细胞在长期体外培养后不会发生转化,也不表现出端粒维持机制。
Cancer Res. 2007 Oct 1;67(19):9142-9. doi: 10.1158/0008-5472.CAN-06-4690.
4
From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells.从细胞基因组学到表观基因组学概况:监测体外培养的人骨髓间充质干细胞的生物学行为
Stem Cell Res Ther. 2012 Nov 20;3(6):47. doi: 10.1186/scrt138.
5
Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma.骨髓间充质基质细胞在骨髓增生异常综合征和多发性骨髓瘤中的常见和不同改变。
Cell Prolif. 2020 May;53(5):e12819. doi: 10.1111/cpr.12819. Epub 2020 May 5.
6
Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.在临床环境下对浆细胞疾病进行基因组分析:在骨髓 CD138 选择后进行微阵列和 FISH 的整合。
J Clin Pathol. 2014 Jan;67(1):66-9. doi: 10.1136/jclinpath-2013-201691. Epub 2013 Aug 22.
7
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.来自骨髓增生异常综合征(MDS)患者的扩增和未培养间充质干细胞在基因组上均存在异常,表现出5q-综合征的特定遗传特征。
Leukemia. 2009 Apr;23(4):664-72. doi: 10.1038/leu.2008.361. Epub 2009 Jan 8.
8
Mesenchymal stem cell abnormalities in patients with multiple myeloma.多发性骨髓瘤患者的间充质干细胞异常
Leuk Lymphoma. 2007 Oct;48(10):2032-41. doi: 10.1080/10428190701593644.
9
Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH.多发性骨髓瘤患者通过全基因组分析和 FISH 联合分析两个 B 细胞亚群中的细胞遗传学异常发生率。
Neoplasma. 2014;61(1):48-55.
10
Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.骨髓基质间充质细胞中 AURKA 和 AURKB 基因的差异表达:与 G 带分析和 FISH 的相关性。
Exp Hematol. 2013 Feb;41(2):198-208. doi: 10.1016/j.exphem.2012.10.009. Epub 2012 Oct 22.

引用本文的文献

1
Chromosomal abnormalities of mesenchymal stromal cells in hematological malignancies.血液系统恶性肿瘤中间充质基质细胞的染色体异常。
Oncogene. 2025 Aug 14. doi: 10.1038/s41388-025-03528-4.
2
Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword.多发性骨髓瘤患者骨髓微环境中的间充质基质细胞:一把双刃剑。
Cancer Cell Int. 2025 Mar 26;25(1):117. doi: 10.1186/s12935-025-03741-x.
3
Extramedullary Multiple Myeloma: Challenges and Opportunities.髓外多发性骨髓瘤:挑战与机遇
Curr Oncol. 2025 Mar 20;32(3):182. doi: 10.3390/curroncol32030182.
4
A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.促炎干细胞龛通过可靶向的半乳糖凝集素-1 轴驱动骨髓纤维化。
Sci Transl Med. 2024 Oct 9;16(768):eadj7552. doi: 10.1126/scitranslmed.adj7552.
5
Characterization of the biological and transcriptomic landscapes of bone marrow-derived mesenchymal stem cells in patients with multiple myeloma.多发性骨髓瘤患者骨髓间充质干细胞的生物学和转录组学特征分析
Cancer Cell Int. 2024 Mar 27;24(1):116. doi: 10.1186/s12935-024-03308-2.
6
Bone marrow inflammation in haematological malignancies.血液恶性肿瘤中的骨髓炎症。
Nat Rev Immunol. 2024 Aug;24(8):543-558. doi: 10.1038/s41577-024-01003-x. Epub 2024 Mar 15.
7
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease.多发性骨髓瘤相关骨病治疗的新进展
Cancers (Basel). 2023 Nov 25;15(23):5585. doi: 10.3390/cancers15235585.
8
Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma.多发性骨髓瘤中骨髓间充质和成骨细胞的分子特征。
Int J Mol Sci. 2022 Dec 7;23(24):15448. doi: 10.3390/ijms232415448.
9
Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche.多发性骨髓瘤中的耐药性:骨髓微环境中的“士兵”与“武器”
Front Oncol. 2022 Sep 21;12:973836. doi: 10.3389/fonc.2022.973836. eCollection 2022.
10
Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells.抑制多发性骨髓瘤相关间充质干细胞中的PI3K-AKT-mTOR信号传导可阻碍多发性骨髓瘤细胞的增殖。
Front Oncol. 2022 Jun 20;12:874325. doi: 10.3389/fonc.2022.874325. eCollection 2022.